SEC 13F Intelligence

Davis-Rea Ltd. / ABT

Davis-Rea Ltd.’s Abbott Laboratories Position

Does Davis-Rea Ltd. own Abbott Laboratories (ABT)? Yes40.8K shares worth $4M (+1.09% of its 13F portfolio) as of Q1 2026, up from 36.5K shares the prior filed quarter.

Position Value
$4M
Q1 2026
Shares
40.8K
% of Portfolio
+1.09%
Quarters Held
5
currently held

Position History ABT

Reported value by quarter
Q1 ’25: $5MQ1 ’25Q2 ’25: $5MQ2 ’25Q3 ’25: $5MQ3 ’25Q4 ’25: $5MQ4 ’25Q1 ’26: $4MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202640.8K$4M+1.09%
Q4 202536.5K$5M+1.14%
Q3 202535.9K$5M+1.17%
Q2 202536.7K$5M+1.24%
Q1 202538.4K$5M+1.36%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Davis-Rea Ltd.’s full portfolio or all institutional holders of ABT.